Aripiprazole (EBC-12081)
Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
57260-67-0
Purity
95%
1-(3,4-Dichlorophenyl)piperazine inhibits beta-1 adrenergic receptor with pKi = 6.67.
Properties
Name
1-(3,4-Dichlorophenyl)piperazine
Smiles
ClC=1C=CC(=CC1Cl)N2CCNCC2
Targets
Please log in to see this information
The impurity for drugs
SDS
1-(3,4-dichloro)phenylpiperazine | 3,4-dichlorophenylpiperazine | 4-(3,4-dichlorophenyl)piperazine | Aripiprazole 3,4-Dichlorophenyl Piperazine Impurity
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
1-(3,4-dichloro)phenylpiperazine | 3,4-dichlorophenylpiperazine | 4-(3,4-dichlorophenyl)piperazine | Aripiprazole 3,4-Dichlorophenyl Piperazine Impurity
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.